Glaxo Smith Kline

Type
Closure
Country
United Kingdom
Region
South East (England); Surrey, East and West Sussex; West Sussex (North East)
Location of affected unit(s)
Crawley
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
493 jobs
Number of planned job losses
Job loss
Announcement Date
10 July 2008
Employment effect (start)
10 July 2008
Foreseen end date
30 December 2011

Description

Pharmesutical giant GlaxoSmithKline (GSK) has announced the closure of its factory in Crawley with the loss of almost 500 jobs. The job losses will be implemented by the end of 2011. The company has blamed the closure on "declining volumes, regulatory delays and patent expiries". Staff at the site currently manufacture prescription medications including medicines to treat Parkinson's disease, heart disease, HIV/AIDS, bacterial skin infections, depression, and hypertension. Consultation with trade unions at the site are due to start immediately.

Sources

  • 10 July 2008: BBC Website

Citation

Eurofound (2008), Glaxo Smith Kline, Closure in United Kingdom, factsheet number 66836, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/66836.